Terry Gould

Directeur/Membre du Conseil chez Orbus Therapeutics, Inc.

Profil

Elisha P.
Gould is currently Director at Orbus Therapeutics, Inc. since 2015, Director at Partner Therapeutics, Inc. since 2018, and Director at Qpex Biopharma, Inc. Former positions include Director at Proteus Digital Health, Inc., Independent Director at Mereo BioPharma 5, Inc. from 2012 to 2017, Director at Light Sciences Oncology, Inc., Director at Naurex, Inc., Director at Incline Therapeutics, Inc., Director at Syneos Health NC LLC, Director at Allegis Corp., Director at Revivant Corp., Director at INC Research, Inc., Director at LifeBond Ltd., Director at Neuraltus Pharmaceuticals, Inc., Director at Atox Bio Ltd., Independent Director at Aptinyx, Inc. from 2015 to 2023, Director at Fusion Pharmaceuticals, Inc., Independent Director at Icosavax, Inc. from 2019 to 2022, Independent Director at Corvus Pharmaceuticals, Inc. from 2014 to 2025, Director at Outpost Medicine, Inc., Principal at UBS Asset Management (Americas) LLC, Principal at Trinity Ventures Ltd., and Management Consultant at The Boston Consulting Group, Inc. Education includes an undergraduate degree from Dartmouth College conferred in 1979 and an MBA from Stanford Graduate School of Business.

Postes actifs de Terry Gould

Sociétés	Poste	Début
Orbus Therapeutics, Inc.	Directeur/Membre du Conseil	01/08/2015
Partner Therapeutics, Inc.	Directeur/Membre du Conseil	07/03/2018
Qpex Biopharma, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Terry Gould

Sociétés	Poste	Fin
CORVUS PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	12/06/2025
APTINYX	Directeur/Membre du Conseil	04/05/2023
ICOSAVAX, INC.	Directeur/Membre du Conseil	10/06/2022
ONCOMED PHARMACEUTICALS INC	Directeur/Membre du Conseil	01/06/2017
Incline Therapeutics, Inc.	Directeur/Membre du Conseil	-